Herman, J F <br/><br/>
Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.  [electronic resource] 

 -  Oncogene  May 2006 
 - 3049-58 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1209324  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--deficiency<br/>Adenocarcinoma--enzymology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Breast Neoplasms--enzymology<br/>Cell Adhesion--drug effects<br/>Cell Line, Tumor--drug effects<br/>Culture Media, Serum-Free--pharmacology<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm--genetics<br/>Enzyme Induction<br/>Female<br/>Fibronectins--metabolism<br/>Focal Adhesion Kinase 1--physiology<br/>GTP-Binding Proteins<br/>Humans<br/>Integrin alpha4--metabolism<br/>Integrin alpha5--metabolism<br/>Integrin beta Chains--metabolism<br/>Integrin beta1--metabolism<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Protein Glutamine gamma Glutamyltransferase 2<br/>RNA, Small Interfering--pharmacology<br/>Transglutaminases--antagonists & inhibitors